Pharmaceutical Jurisprudence MCQ Quiz in मल्याळम - Objective Question with Answer for Pharmaceutical Jurisprudence - സൗജന്യ PDF ഡൗൺലോഡ് ചെയ്യുക

Last updated on Mar 26, 2025

നേടുക Pharmaceutical Jurisprudence ഉത്തരങ്ങളും വിശദമായ പരിഹാരങ്ങളുമുള്ള മൾട്ടിപ്പിൾ ചോയ്സ് ചോദ്യങ്ങൾ (MCQ ക്വിസ്). ഇവ സൗജന്യമായി ഡൗൺലോഡ് ചെയ്യുക Pharmaceutical Jurisprudence MCQ ക്വിസ് പിഡിഎഫ്, ബാങ്കിംഗ്, എസ്എസ്‌സി, റെയിൽവേ, യുപിഎസ്‌സി, സ്റ്റേറ്റ് പിഎസ്‌സി തുടങ്ങിയ നിങ്ങളുടെ വരാനിരിക്കുന്ന പരീക്ഷകൾക്കായി തയ്യാറെടുക്കുക

Latest Pharmaceutical Jurisprudence MCQ Objective Questions

Top Pharmaceutical Jurisprudence MCQ Objective Questions

Pharmaceutical Jurisprudence Question 1:

Medicinal & Toilet preparations (Excise duties) Act was passed in the year

  1. 1950
  2. 1955
  3. 1960
  4. 1965

Answer (Detailed Solution Below)

Option 2 : 1955

Pharmaceutical Jurisprudence Question 1 Detailed Solution

Correct Answer: 1958
Rationale:
  • The Medicinal & Toilet Preparations (Excise Duties) Act was enacted in the year 1955. This legislation was formulated to regulate the excise duties on medicinal and toilet preparations containing alcohol, opium, Indian hemp, or other narcotic drugs.
  • The primary objective of the Act was to control and monitor the production, distribution, and taxation of these products, ensuring that they are used for legitimate purposes and preventing misuse.
  • The Act also aimed to ensure that the government could generate revenue from the excise duties levied on these products.
Explanation of Other Options:
1950
  • Rationale: The year 1950 is not correct because the Medicinal & Toilet Preparations (Excise Duties) Act was not enacted in this year. This year is significant in Indian history as it marks the adoption of the Indian Constitution.
1960
  • Rationale: The year 1960 is also incorrect. Although many important laws were passed around this time, the Medicinal & Toilet Preparations (Excise Duties) Act was already in effect by then.
1965
  • Rationale: The year 1965 is incorrect. By this time, the Medicinal & Toilet Preparations (Excise Duties) Act had already been in place for several years, having been enacted in 1958.
Conclusion:
  • Among the given options, the correct year in which the Medicinal & Toilet Preparations (Excise Duties) Act was enacted is 1955. This legislation was crucial in regulating and monitoring the use of alcohol and narcotic drugs in medicinal and toilet preparations, as well as in generating revenue through excise duties.

Pharmaceutical Jurisprudence Question 2:

The name of the registered pharmacist can be removed from the register by the excutive committee, if it is found that 

  1. His name has been entered by error or an account of misrepresentation or suppression of material fact
  2. He has been convicted of any offence or has been guilty of any infamous conduct n any professional respect
  3. Both of A & B
  4. None of above

Answer (Detailed Solution Below)

Option 3 : Both of A & B

Pharmaceutical Jurisprudence Question 2 Detailed Solution

Correct Answer: Both of A & B
Rationale:
  • The registered pharmacist's name can be removed from the register by the executive committee if certain conditions are met. The two main conditions are:
  • 1) His name has been entered by error or on account of misrepresentation or suppression of material fact.
  • 2) He has been convicted of any offence or has been guilty of any infamous conduct in any professional respect.
  • These two conditions cover both administrative errors and ethical breaches.
Explanation of Other Options:
His name has been entered by error or on account of misrepresentation or suppression of material fact
  • Rationale: While this is a valid reason for removal, it is not the only reason. The executive committee can also remove a name for ethical breaches.
He has been convicted of any offence or has been guilty of any infamous conduct in any professional respect
  • Rationale: This is another valid reason for removal, but it is not the only reason. Administrative errors can also justify removal.
None of above
  • Rationale: This option is incorrect because both administrative errors and ethical breaches are valid reasons for removal.
Conclusion:
  • The registered pharmacist's name can be removed from the register by the executive committee if it is found that his name has been entered by error or on account of misrepresentation or suppression of material fact, or if he has been convicted of any offence or has been guilty of any infamous conduct in any professional respect. Both conditions are considered valid reasons for removal.

Pharmaceutical Jurisprudence Question 3:

Which is the oldest Act about the drug 

  1. Dangerous drug Act
  2. Opium Act
  3. Poison Act
  4. Drugs Act

Answer (Detailed Solution Below)

Option 2 : Opium Act

Pharmaceutical Jurisprudence Question 3 Detailed Solution

Correct Answer: Opium Act
Rationale:
  • The Opium Act is considered the oldest legislation related to drugs. It was established in the 19th century to regulate the cultivation, production, and distribution of opium.
  • The primary aim of the Opium Act was to control the opium trade and reduce the misuse of opium and its derivatives.
  • The act laid down strict guidelines for the legal trade of opium and imposed penalties for illegal activities related to opium.
Explanation of Other Options:
Dangerous Drug Act
  • Rationale: The Dangerous Drug Act is a more recent legislation compared to the Opium Act. It was designed to control the use of narcotics and other dangerous drugs, focusing on modern synthetic drugs and narcotic substances.
Poison Act
  • Rationale: The Poison Act was created to regulate the sale and distribution of poisons. It is not specifically focused on drugs but rather on substances that can be toxic or lethal, including certain chemicals and compounds.
Drugs Act
  • Rationale: The Drugs Act is a legislation that typically covers a broad range of pharmaceutical substances. It aims to ensure the safety, efficacy, and quality of drugs available to the public. This act is also more recent compared to the Opium Act.
Conclusion:
  • Among the given options, the Opium Act is the oldest legislation specifically related to drugs, focusing on the regulation of opium trade and its derivatives. It predates other acts such as the Dangerous Drug Act, Poison Act, and Drugs Act, which were established later to address broader and more modern concerns related to drug use and safety.
```

Pharmaceutical Jurisprudence Question 4:

Sale prices of bulk drugs is fixed by

  1. Patent Act
  2. MAPE calculation
  3. Factories Act 1948
  4. Drug Price control order (DPCO)

Answer (Detailed Solution Below)

Option 4 : Drug Price control order (DPCO)

Pharmaceutical Jurisprudence Question 4 Detailed Solution

Correct Answer: Drug Price Control Order (DPCO)
Rationale:
  • The Drug Price Control Order (DPCO) is an order issued by the government to regulate the prices of drugs. The primary objective of DPCO is to ensure that essential drugs are available to all sections of the population at reasonable prices.
  • DPCO is enforced by the National Pharmaceutical Pricing Authority (NPPA), which is responsible for setting and revising the prices of controlled bulk drugs and formulations.
  • The order includes a list of drugs that are subject to price control, known as the National List of Essential Medicines (NLEM). The prices of these drugs are fixed based on a formula that considers various factors including the cost of production, market prices, and affordability.
Explanation of Other Options:
Patent Act
  • Rationale: The Patent Act deals with the laws related to the patents of inventions, including pharmaceuticals. It does not regulate the prices of drugs but focuses on the protection of intellectual property rights of inventors.
MAPE Calculation
  • Rationale: MAPE (Maximum Allowable Post-manufacturing Expenses) calculation is a method used to determine the ceiling price of a drug. While it is a component of price regulation, it is not the order that fixes the prices of drugs. The DPCO uses MAPE in its pricing formula.
Factories Act 1948
  • Rationale: The Factories Act 1948 is legislation that regulates labor welfare, safety, and health in factories. It does not deal with the pricing of drugs or any pharmaceutical products.
Conclusion:
  • Among the given options, the Drug Price Control Order (DPCO) is the correct mechanism by which the sale prices of bulk drugs are fixed. This ensures that essential medicines remain affordable and accessible to the general population.

Pharmaceutical Jurisprudence Question 5:

The Act of Narcotic Drug & psychotropic substances includes the study of

  1. Manufacturing of opium and other narcotics drug
  2. Sales of opium
  3. Import & export of narcotics 
  4. All above

Answer (Detailed Solution Below)

Option 4 : All above

Pharmaceutical Jurisprudence Question 5 Detailed Solution

Correct Answer: All above
Rationale:
  • The Act of Narcotic Drugs & Psychotropic Substances (NDPS Act) encompasses a broad range of activities related to narcotic drugs and psychotropic substances to regulate and control their use, distribution, and production.
  • The purpose of the NDPS Act is to ensure that these substances are not misused and are only available for legitimate medical and scientific purposes.
  • The Act also aims to prevent and combat drug abuse and illicit trafficking in narcotic drugs and psychotropic substances.
Explanation of Other Options:
Manufacturing of opium and other narcotic drugs
  • Rationale: The NDPS Act includes provisions for the regulation of the manufacturing process of opium and other narcotic drugs. This is to ensure that the production is controlled and is only used for legitimate purposes.
Sales of opium
  • Rationale: The Act also covers the sale of opium, ensuring that it is only sold through authorized channels and for legal purposes. Unauthorized sale or distribution is strictly prohibited under the Act.
Import & export of narcotics
  • Rationale: The import and export of narcotic drugs and psychotropic substances are regulated under the NDPS Act to prevent illegal trafficking and ensure that these substances are only transported for lawful purposes.
Conclusion:
  • The NDPS Act comprehensively covers the manufacturing, sale, import, and export of narcotic drugs and psychotropic substances. Therefore, the correct answer is "All above," as the Act includes all these aspects to regulate and control the use of these substances effectively.

Pharmaceutical Jurisprudence Question 6:

खालीलपैकी कोणते परिशीष्ट हे "ड्रग्स आणि कॉस्मेटीक्स अॅक्ट" या औषधाच्या विभागणीशी संबंधीत नाही ?

  1. परिशीष्ट 
  2. परिशीष्ट Y
  3. परिशीष्ट G
  4. परिशीष्ट H

Answer (Detailed Solution Below)

Option 2 : परिशीष्ट Y

Pharmaceutical Jurisprudence Question 6 Detailed Solution

Correct Answer: परिशिष्ट Y
Rationale:
  • "ड्रग्स आणि कॉस्मेटिक्स अॅक्ट" हे औषधांच्या निर्मिती, वितरण आणि विक्रीसाठीचे नियम आणि नियमन सांगणारे एक कायदा आहे. या कायद्याच्या परिशिष्टांमध्ये औषधांचे विविध वर्गीकरण आणि त्यांचे नियमन याबाबत माहिती दिलेली आहे.
  • परिशिष्ट Y हे मुख्यतः क्लिनिकल ट्रायल्स आणि त्यांचे नियमन याबाबत माहिती देते, जे औषधांच्या विभागणीशी थेट संबंधित नाही.
Explanation of Other Options:
परिशिष्ट A
  • Rationale: परिशिष्ट A हे औषधांच्या निर्मितीमध्ये वापरण्यात येणाऱ्या घटकांबाबत माहिती देते आणि हे औषधांच्या विभागणीशी संबंधित आहे.
परिशिष्ट G
  • Rationale: परिशिष्ट G हे विशेष औषधांच्या तक्त्यांबद्दल माहिती देते, जसे की विशिष्ट परिस्थितींमध्ये वापरण्यात येणारी औषधे, आणि हे औषधांच्या विभागणीशी संबंधित आहे.
परिशिष्ट H
  • Rationale: परिशिष्ट H हे प्रिस्क्रिप्शन औषधांच्या यादीबद्दल माहिती देते, जे डॉक्टर्सच्या प्रिस्क्रिप्शनशिवाय विकत घेता येत नाहीत, आणि हे औषधांच्या विभागणीशी संबंधित आहे.
Conclusion:
  • वरील पर्यायांपैकी, परिशिष्ट Y हा एकमेव असा परिशिष्ट आहे जो औषधांच्या विभागणीशी थेट संबंधित नाही. तो मुख्यतः क्लिनिकल ट्रायल्सच्या नियमनाशी संबंधित आहे.

Pharmaceutical Jurisprudence Question 7:

WHO GMP प्रमाणपत्र हे औषधनिर्मात्यास कोण प्रदान करतो ?

  1. एफडीए
  2. डीसीजीआय
  3. सीडीएससीओ
  4. WHO

Answer (Detailed Solution Below)

Option 1 : एफडीए

Pharmaceutical Jurisprudence Question 7 Detailed Solution

Correct Answer: WHO
Rationale:
  • The WHO GMP (Good Manufacturing Practice) certificate is issued by the World Health Organization (WHO). This certification ensures that pharmaceutical manufacturing processes meet international standards of quality, safety, and efficacy.
  • WHO GMP certification is crucial for manufacturers looking to market their pharmaceutical products globally, as it signifies compliance with internationally recognized quality standards.
  • The certification process involves rigorous inspections and evaluations of manufacturing facilities, quality control systems, and documentation practices to ensure that products are consistently produced and controlled according to quality standards.
Explanation of Other Options:
FDA
  • Rationale: The Food and Drug Administration (FDA) is a regulatory body in the United States responsible for protecting public health by ensuring the safety, efficacy, and security of drugs, biological products, and medical devices. While the FDA issues GMP certificates for products sold in the U.S., it does not issue WHO GMP certificates.
DCGI
  • Rationale: The Drug Controller General of India (DCGI) is the head of the Central Drugs Standard Control Organization (CDSCO) in India. DCGI is responsible for the approval of new drugs and clinical trials in India, as well as the issuance of GMP certificates for the Indian market. However, it does not issue WHO GMP certificates.
CDSCO
  • Rationale: The Central Drugs Standard Control Organization (CDSCO) is the national regulatory body for pharmaceuticals and medical devices in India. While CDSCO ensures compliance with Indian GMP standards, it does not issue WHO GMP certificates.
Conclusion:
  • Among the given options, the WHO is the correct organization that issues WHO GMP certificates. This certification is essential for pharmaceutical manufacturers aiming to meet international quality standards and market their products globally.

Pharmaceutical Jurisprudence Question 8:

सरकारी नियमानुसार औषधभांडार कक्षाकरिता मल्टीस्पेशीयालिटी रुग्णालयात _______ स्के. फुट/ बेड एवढी जागा लागते.

  1. एक 
  2. दोन
  3. पाच
  4. दहा

Answer (Detailed Solution Below)

Option 3 : पाच

Pharmaceutical Jurisprudence Question 8 Detailed Solution

Correct Answer: पाच
रॅशनल:
  • सरकारी नियमानुसार, मल्टीस्पेशीयालिटी रुग्णालयातील औषधभांडार कक्षाकरिता दर बेडसाठी ५ स्के. फुट जागा लागते. हे नियम रुग्णालयातील औषधसाठा योग्य प्रकारे ठेवण्यासाठी आणि व्यवस्थापनासाठी आवश्यक आहेत.
  • ५ स्के. फुट जागा ही प्रमाणित माप आहे, जी औषधभांडार कक्षाच्या कार्यक्षमतेसाठी आणि सुरक्षा सुनिश्चित करण्यासाठी पुरेशी आहे.
इतर पर्यायांचे स्पष्टीकरण:
एक
  • रॅशनल: एक स्के. फुट जागा औषधभांडार कक्षासाठी अत्यंत कमी आहे. यामुळे औषधांचे योग्य व्यवस्थापन आणि साठवणूक होणे शक्य नाही.
दोन
  • रॅशनल: दोन स्के. फुट जागा देखील औषधभांडार कक्षासाठी अपुरी आहे. यामुळे औषधांच्या व्यवस्थापनात अडचणी येऊ शकतात.
दहा
  • रॅशनल: दहा स्के. फुट जागा ही प्रमाणापेक्षा जास्त आहे. यामुळे औषधभांडार कक्षाची जागा अयोग्य प्रमाणात वापरली जाते.
निष्कर्ष:
  • मल्टीस्पेशीयालिटी रुग्णालयातील औषधभांडार कक्षासाठी ५ स्के. फुट दर बेड ही योग्य आणि प्रमाणित जागा आहे. त्यामुळे औषधांचे योग्य व्यवस्थापन आणि साठवणूक सुनिश्चित होते.

Pharmaceutical Jurisprudence Question 9:

The Schedule to which 'List of drugs to be sold on prescription only' belong to.

  1. Schedule H
  2. Schedule W
  3. Schedule X
  4. Schedule M.

Answer (Detailed Solution Below)

Option 1 : Schedule H

Pharmaceutical Jurisprudence Question 9 Detailed Solution

Correct Answer: Schedule H
Rationale:
  • The "List of drugs to be sold on prescription only" belongs to Schedule H. Schedule H drugs are those medications that can only be sold with a prescription from a registered medical practitioner.
  • These drugs include antibiotics, antifungals, and other medications that require professional supervision due to their potential side effects and need for proper dosage management.
  • The label of Schedule H drugs must bear the inscription "Rx" and a warning stating it should only be dispensed on a prescription.
Explanation of Other Options:
Schedule W
  • Rationale: There is no Schedule W in the current classification system for drugs and pharmaceuticals.
Schedule X
  • Rationale: Schedule X drugs are a subset of Schedule H drugs but with more stringent controls due to their higher potential for abuse and addiction. While Schedule X drugs also require a prescription, they are handled separately under stricter regulations.
Schedule M
  • Rationale: Schedule M deals with the good manufacturing practices (GMP) and requirements for premises, plant, and equipment for pharmaceutical products. It does not relate to prescription-only drugs.
Conclusion:
  • The correct schedule for the list of drugs that are to be sold only on prescription is Schedule H. This classification ensures that such drugs are used appropriately and safely under medical supervision.

Pharmaceutical Jurisprudence Question 10:

The ex-officio member of Pharmacy Council of India is.

  1. Teacher in Pharmacology
  2. A member from MCI 
  3. A representative of UGC
  4. Director of CDL

Answer (Detailed Solution Below)

Option 4 : Director of CDL

Pharmaceutical Jurisprudence Question 10 Detailed Solution

Correct Answer: Director of CDL
Rationale:
  • The Pharmacy Council of India (PCI) is a statutory body governed by the provisions of the Pharmacy Act, 1948. It regulates the profession and practice of pharmacy in India.
  • An ex-officio member is someone who is part of a body by virtue of holding a particular office. In this case, the Director of the Central Drugs Laboratory (CDL) is an ex-officio member of the PCI.
Explanation of Other Options:
Teacher in Pharmacology
  • Rationale: A teacher in pharmacology can be a member of various academic and professional bodies, but they are not an ex-officio member of the Pharmacy Council of India. Their membership would typically be based on election or nomination rather than an ex-officio basis.
A member from MCI
  • Rationale: The Medical Council of India (MCI) oversees medical education and practice, not pharmacy. Therefore, a member from MCI would not be an ex-officio member of the Pharmacy Council of India.
A representative of UGC
  • Rationale: The University Grants Commission (UGC) is responsible for coordinating, determining, and maintaining standards of higher education. While it may have a role in pharmacy education, a UGC representative is not an ex-officio member of the PCI.
Conclusion:
  • Among the given options, the Director of the Central Drugs Laboratory (CDL) is the correct answer as the ex-officio member of the Pharmacy Council of India. This position is specified in the Pharmacy Act, 1948, ensuring a direct link between the regulatory body and the key laboratory responsible for drug testing and standards.
Get Free Access Now
Hot Links: teen patti gold downloadable content teen patti rich teen patti win